Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Amioka · SciRah

Researcher profile · Semantic Scholar

K. Amioka

Share profile

K. Amioka — researcher profile on SciRah

h-index: 9
Works: 32
Citations: 301

Most-cited papers

Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
Yuwa Ando, T. Kawaoka, K. Amioka, Kensuke Naruto +27 more
2021Oncology45 citations
Semantic Scholar
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice
Yuwa Ando, T. Kawaoka, Masanari Kosaka, Yuki Shirane +19 more
2021Cancers41 citations Open access
Semantic Scholar
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein
Yumi Kosaka, Tomoki Kimura, T. Kawaoka, Yutaro Ogawa +20 more
2021Liver Cancer40 citations Open access
Semantic Scholar
Lenvatinib activates anti-tumor immunity by suppressing immunoinhibitory infiltrates in the tumor microenvironment of advanced hepatocellular carcinoma
M. Yamauchi, A. Ono, K. Amioka, Yasutoshi Fujii +20 more
2023Communications Medicine38 citations Open access
Semantic Scholar
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
Yuwa Ando, T. Kawaoka, Masanari Kosaka, Yuki Shirane +18 more
2022Liver Cancer17 citations Open access
Semantic Scholar
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
Shigeki Yano, T. Kawaoka, Shintaro Yamasaki, Yusuke Johira +20 more
2023Cancers15 citations Open access
Semantic Scholar
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
K. Amioka, T. Kawaoka, Masanari Kosaka, Yusuke Johira +32 more
2022Cancers11 citations Open access
Semantic Scholar
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein
Takahiro Kinami, K. Amioka, T. Kawaoka, S. Uchikawa +19 more
2023Cancers10 citations Open access
Semantic Scholar
Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
Shigeki Yano, T. Kawaoka, Yusuke Johira, Ryoichi Miura +23 more
2021Medicine9 citations Open access
Semantic Scholar
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab
Chihiro Kikugawa, S. Uchikawa, T. Kawaoka, Takahiro Kinami +23 more
2023Oncology8 citations
Semantic Scholar
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment
Kenji Yamaoka, Kenichiro Kodama, T. Kawaoka, Masanari Kosaka +22 more
2022PLoS ONE8 citations Open access
Semantic Scholar
Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma
K. Amioka, T. Kawaoka, Takahiro Kinami, Shintaro Yamasaki +28 more
2022Cancers7 citations Open access
Semantic Scholar
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy
K. Amioka, T. Kawaoka, Yutaro Ogawa, Chihiro Kikukawa +23 more
2021Oncology7 citations
Semantic Scholar
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib
Kikukawa Chihiro, T. Kawaoka, S. Uchikawa, Takahiro Kinami +21 more
2023Oncology6 citations
Semantic Scholar
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions
Shigeki Yano, T. Kimura, T. Kawaoka, Takahiro Kinami +20 more
2023Cancers6 citations Open access
Semantic Scholar
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices
Yuki Shirane, E. Murakami, M. Imamura, Masanari Kosaka +22 more
2022BMC Gastroenterology6 citations Open access
Semantic Scholar
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection
Kenichiro Kodama, T. Kawaoka, Masanari Kosaka, Yusuke Johira +21 more
2022Journal of gastroenterology5 citations
Semantic Scholar
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma
Kensuke Naruto, T. Kawaoka, K. Amioka, Yutaro Ogawa +31 more
2021Oncology4 citations
Semantic Scholar
Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study
Kensuke Naruto, T. Kawaoka, Kenichiro Kodama, Yutaro Ogawa +22 more
2021BMC Gastroenterology4 citations Open access
Semantic Scholar
Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study
Ko Hashimoto, T. Kawaoka, Tomoaki Emori, Aiko Tanaka +30 more
2025Liver Cancer3 citations Open access
Semantic Scholar
Influence of dispersion slope on the diagnosis of liver fibrosis by the shear wave in metabolic dysfunction‐associated steatotic liver disease
N. Ueda, S. Mokuda, T. Kawaoka, S. Uchikawa +9 more
2024Hepatology Research3 citations Open access
Semantic Scholar
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma
Takahiro Kinami, S. Uchikawa, T. Kawaoka, Shintaro Yamasaki +16 more
2024Cancer Medicine2 citations Open access
Semantic Scholar
Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma
Yumi Kosaka, T. Kawaoka, Masanari Kosaka, Yuki Shirane +17 more
2022Internal medicine2 citations Open access
Semantic Scholar
Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Yusuke Johira, T. Kawaoka, Masanari Kosaka, Yuki Shirane +24 more
2021Liver Cancer2 citations Open access
Semantic Scholar
Pharmacist intervention through protocol-based pharmacotherapy management is effective to ensure safety in invasive procedures for chronic liver disease
Y. Shibata, Yuki Koga, Yuki Sato, Emiko Mashida +9 more
2025Journal of Pharmaceutical Health Care and Sciences1 citations Open access
Semantic Scholar
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study
Yusuke Johira, T. Nakahara, Takahiro Kinami, Shintaro Yamasaki +22 more
2023BMC Gastroenterology1 citations Open access
Semantic Scholar
Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene
Ryoichi Miura, T. Kawaoka, M. Imamura, Masanari Kosaka +17 more
2022Case Reports in Gastroenterology1 citations Open access
Semantic Scholar
Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.
Kensuke Naruto, T. Kawaoka, Shintaro Yamasaki, Masanari Kosaka +16 more
2023Yonago acta medica0 citations Open access
Semantic Scholar
A patient with chronic hepatitis B who developed hepatocellular carcinoma with hypervascularity in 9 years of close follow-up
Masanari Kosaka, T. Kawaoka, Yusuke Johira, Yuki Shirane +25 more
2022Kanzo0 citations Open access
Semantic Scholar
P-141 Lenvatinib activates potential anti-tumor immunity by increasing infiltration of immune cells and interferon response in tumor microenvironment of advanced hepatocellular carcinoma
M. Yamauchi, A. Ono, K. Amioka, Y. Fujii +15 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
A patient with polycystic liver disease combined with portal hypertension that died due to bacterial peritonitis as a secondary cause of death
Ryoichi Miura, M. Imamura, K. Amioka, Kenichiro Kodama +12 more
2022Kanzo0 citations Open access
Semantic Scholar
Successful multimodality treatment for advanced hepatocellular carcinoma with tumor thrombosis of the main portal trunk: a case study
Yumi Kosaka, T. Kawaoka, Yutaro Ogawa, K. Amioka +15 more
2021Clinical Journal of Gastroenterology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Kawaoka×32
Invite
T. Kawaoka — researcher profile on SciRah
S. Uchikawa×30
Invite
S. Uchikawa — researcher profile on SciRah
E. Murakami×28
Invite
E. Murakami — researcher profile on SciRah
Kensuke Naruto×27
Invite
Kensuke Naruto — researcher profile on SciRah

×27

Invite

T. Nakahara — researcher profile on SciRah

Invite

H. Aikata — researcher profile on SciRah

Invite

H. Fujino — researcher profile on SciRah

M. Yamauchi×25

Invite

M. Yamauchi — researcher profile on SciRah

Invite

M. Imamura — researcher profile on SciRah

Invite

Yuwa Ando — researcher profile on SciRah

Yumi Kosaka×20

Invite

Yumi Kosaka — researcher profile on SciRah

Yusuke Johira×20

Invite

Yusuke Johira — researcher profile on SciRah